viernes, 7 de febrero de 2025

Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real-world evidence.

https://read.qxmd.com/read/39031440/multiple-myeloma-refractory-to-lenalidomide-a-systematic-literature-review-of-trials-and-real-world-evidence?uac=148436CN&ecd=wnl_readmost_250207&sso=true&redirected=slug Multiple myeloma refractory to lenalidomide: A systematic literature review of trials and real-world evidence. The growing use of frontline lenalidomide treatment in multiple myeloma (MM) is increasing the proportion of lenalidomide-refractory patients, which may limit t.. Sep 2024: British Journal of Haematology

No hay comentarios:

Publicar un comentario